Mind-Altering
Drugs and the Future A researcher in psychopharmacology foresees a growing flood of new drugs that will make man feel happy, cause him to forget his past, arouse his sexual desires, and give him dreams. The dawning of an era of chemically-induced bliss gives new urgency to the ancient conundrum of the philosophers: "Which is better-a happy pig or an unhappy Socrates?" In the coming decades, man may actually have the possibility of attaining sustained happiness-or something like it through drugs, and so must ask 'the question, "Is happiness what I most want?"
by Wayne O. Evans
A study of man shows that throughout recorded history, and in almost every culture, people have taken chemical substances to change their mood, perception and/or thought processes. The earliest recording about such drugs seems to be the hymns of praise sung to "Soma," the magic mushroom of the Aryan invaders of India, found in the Vedas. These indicate its use came from northeastern Eu rope and had existed since 2000 B.C. Later, about 1500 B.C., the Eber Papyrus documents the use of wine by the Egyptians. The opium poppy, Papaver somniferum, appears in records as early as 1000 B.C., and documents from Meso potamia indicate the use of cannabis (Indian hemp) as a psychotropic drug at least by 500 B.C. The ancient Indian civilizations of Mexico and South America used mind altering chemicals, e.g., cocaines, tropines, harmines and indoles of various types. Farther west, the natives of the Pacific islands used betel and kava kava, while in Asia, nat ural products which yield ephedrine and reserpine were common in medical practices. Closer to home, we can con sider our own history of opiate usage, laughing gas or ether sniffing parties, cocaine epidemics and a tradition of ex cessive use of alcohol. Obviously, man always has sought chemical methods to alter his mind and this tendency has not abated and may even have grown in modern times. Psychotropic Drugs Pour into Market Today, medicinal and biochemistry, animal and clinical The material presented here is the opinion of the author and should not be considered as reflecting any policy or position of the U.S. Department of Defense.
THE FUTURIST, JUNE 7977
psychopharmacology, neurophysiology and neuroanatomy are 'advancing at the same rapid rate as the other biological sciences. Thousands of chemicals are tested each year for potential psychotropic properties. Expeditions have been launched to such dissimilar environments as the upper Congo and the continental shelf in search of new plants or animals which might yield chemicals to alter the mind. New psychotropic drugs have the highest rate of entry onto the market of all types of drugs. Further, our techniques of testing new chemicals for psychotropic properties, in both animals and man, have been refined to the point that one would be hard pressed to name a mood, mode of perception or mental function which now is not testable and roughly quantifiable. Due to this heightened skill in science and technology, we are achieving a potency and specificity of action in drugs which previously would have been impossible. As an ex ample, K. W. Bentley has synthesized an opiate-like sub stance which is ten thousand times as potent as morphine. This means that the average effective dose for a human being is 1.5 micrograms to achieve an analgetic equivalence with the usual dose of morphine given for postoperative pain relief. Another example of the capability to produce more potent and specific drugs is the development of certain diazepoxides (Librium ®) which can induce sleep at a dose as low as 0.5 mg. We finally may have produced a com pound which will live up to the fabled "knock-out" drops of spy fiction. 101